Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan;167(1):365-366.
doi: 10.1016/j.jtcvs.2023.09.014. Epub 2023 Sep 12.

Commentary: Segmentectomy versus lobectomy: Are the findings of the JCOG 0802 and CALGB 140503 trials generalizable to the US population?

Steven Tohmasi  1 , Varun Puri  2
Affiliations
Editorial

Commentary: Segmentectomy versus lobectomy: Are the findings of the JCOG 0802 and CALGB 140503 trials generalizable to the US population?

Steven Tohmasi et al. J Thorac Cardiovasc Surg. 2024 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement Dr Tohmasi was supported by the Washington University School of Medicine Surgical Oncology Basic Science and Translational Research Training Program (grant T32CA009621) from the National Cancer Institute (NCI). Dr Puri was supported in part by the NCI (grant R01CA258681). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.

Figures

Central Picture:
Central Picture:
Steven Tohmasi, MD (left) and Varun Puri, MD, MSCI (right).
See this image and copyright information in PMC

Comment on

References

    1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995. Sep;60(3):615–22; discussion 622–3. - PubMed
    1. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 3.2023. Accessed 2023 July 26.
    1. Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022. Apr 23;399(10335):1607–1617. - PubMed
    1. Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, Port J, Jones DR, Conti M, Ashrafi AS, Liberman M, Yasufuku K, Yang S, Mitchell JD, Pass H, Keenan R, Bauer T, Miller D, Kohman LJ, Stinchcombe TE, Vokes E. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023. Feb 9;388(6):489–498. - PMC - PubMed
    1. Potter AL, Kim J, McCarthy ML, Senthil P, Mathey-Andrews C, Kumar A, Cao C, Lin MW, Lanuti M, Martin LW, Yang CJ. Segmentectomy versus Lobectomy in the United States. J Thorac Cardiovasc Surg. 2023: in press. - PubMed